Related Experiment Video
Updated: May 28, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
[Immunotherapy of melanoma]
1Dermato-cancérologie, Unité thérapie cellulaire et génique, CHU Nantes, Place Alexis Ricordeau - 44093 cedex 01. brigitte.dreno@wanadoo.fr
Bulletin De L'Academie Nationale De Medecine
|November 3, 2011
Summary
Understanding how melanoma tumors create immune tolerance is key to improving non-specific immunotherapy, vaccination, and adoptive immunotherapy. This knowledge is crucial for realizing the full potential of these melanoma treatments.
Area of Science:
- Immunology
- Oncology
- Cancer Therapy
Background:
- Melanoma treatment landscape includes immunotherapy and vaccination strategies.
- Current immunotherapies for melanoma face challenges in efficacy.
- Tumor-induced immune tolerance is a significant barrier in cancer treatment.
Purpose of the Study:
- To review current concepts in melanoma immunotherapy.
- To identify future challenges in melanoma treatment.
- To highlight the importance of understanding tumor-induced immune tolerance.
Main Methods:
- Literature review of non-specific immunotherapy, vaccination, and antigen-specific adoptive immunotherapy for melanoma.
- Analysis of mechanisms of tumor immune tolerance.
Main Results:
- Current immunotherapeutic approaches for melanoma are discussed.
- Key challenges and future directions are outlined.
- The critical role of tumor immune tolerance is emphasized.
Conclusions:
- Further research into tumor immune tolerance is essential for advancing melanoma immunotherapy.
- Overcoming immune tolerance is vital for the success of melanoma vaccination and adoptive immunotherapy.
- A deeper understanding of melanoma's immune evasion strategies will improve treatment outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...